News
Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-USA) specialty pharmaceutical company, will release its second quarter 2025 financial results on Thursday, August 7, 2025 prior to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback